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Abstract 
 
A  52-year-old  diabetic  man  presented  to  the  Emergency 
Department with a history of fevers and pain in his right 
thigh.  He  had  recently  returned  from  a  10-month  trip  to 
Vietnam. A suspected bacterial abscess in the right thigh did 
not  respond  to  empirical  antibiotics.  Subsequent 
investigations  revealed  melioidotic  osteomyelitis  of  the 
femur.  This  case  emphasises  the  need  to  consider  the 
diagnosis  of  melioidosis  in  patients  presenting  with  fever 
following travel in endemic areas. 
Key Words 
Fever in returned traveller, melioidosis, osteomyelitis 
 
Background 
Melioidosis  is  a  disease  endemic  in  Southeast  Asia  and 
northern  Australia.
1  It  is  caused  by  Burkholderia 
pseudomallei,  an  environmental  saprophyte.
2  Infection  is 
thought  to  arise  by  direct  inoculation  with  contaminated 
water  or  soil,  and  diabetes  is  a  strong  risk  factor  for 
infection.
2,3  Most  people  who  are  infected  remain 
asymptomatic  and  infection  can  remain  latent  for  years. 
Melioidosis  is  rarely  seen  as  an  imported  infection  in 
Australia.  We  describe  the  diagnostic  challenge  of  an 
unusual  case  of  melioidotic  osteomyelitis  presenting  as 
fever in a returned traveller. 
 
Case details 
A 52-year-old Vietnamese man presented to the Emergency 
Department with a five-day history of intermittent fevers, 
rigors, headache and myalgia.  He complained of a dull ache 
in the right thigh but no other localising symptoms.  The 
patient had returned to Australia after a 10-month trip to 
metropolitan  Vietnam.  He  had  been  hospitalised  twice 
while in Vietnam with similar presentations but could not 
recall  any  specific  diagnoses  or  treatment.  He  was  not 
provided  with  any  documentation  pertaining  to  his 
admissions.  No travel vaccinations were taken prior to the 
trip.  There  were  no  infectious  contacts  or  sexual  activity 
whilst abroad.  He had stable type 2 diabetes mellitus and 
treated hypercholesterolemia and there was a past history 
of  hepatitis  B  and  traumatic  injury  to  the  left  knee  both 
without sequelae.   
 
At presentation he had a fever of 38.6°C. Examination of the 
cardiovascular, respiratory and gastrointestinal systems was 
unremarkable.  He had dark tender indurated plaques on his 
right lateral thigh.  There was a hypertrophic scar overlying 
the left anterior knee from a previous motorcycle accident.  
A  full  blood  count  and  serum  biochemistry  were  within 
normal  limits.  The  C-reactive  protein  was  50mg/L.   
Repeated blood and urine cultures were negative. A malaria 
screen,  serum  electrophoresis,  flavivirus  and  hydatid 
serology  were  all  negative.  The  chest  X-ray  was  normal.  
Empirical  treatment  for  a  suspected  thigh  abscess  was 
commenced with flucloxacillin, ceftriaxone and vancomycin. 
 
An ultrasound of his right thigh showed multiple cystic areas 
in  the  subcutaneous  tissue  layer.  Punch  biopsies  of  the 
plaques on his thigh showed dermal mucin and a lympho-
histiocytic response but no causative organism was found 
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on Gram stain and culture. A plain X-ray of the right femur 
revealed a lytic lesion within the medulla (Figure 1a). This 
correlated with non-specific focal uptake on bone scan and 
a multiloculated lytic lesion on computed tomography (CT) 
scan of the right femur, suggestive of either osteomyelitis or 
malignancy (Figure 1b & 1c). 
 
A CT of the chest, abdomen and pelvis was performed in 
search of either a primary source or other foci.  CT findings 
revealed  mild  right  upper  lobe  fibrosis  of  unknown 
significance and multiple round splenic hypodense lesions 
consistent  with  pyogenic  abscesses  (Figure  1d  &  1e). 
Tuberculosis  was  strongly  suspected  and  the  patient 
underwent  bronchoscopy.  Bronchoalveolar  lavage 
specimens were Ziehl-Neelsen stain negative and negative 
for growth on standard bacterial and mycobacterial culture. 
A Quantiferon Gold assay was also negative.   
 
Figure 1: (a) Plain X-ray right femur showing a lytic lesion 
within  the  medulla.  (b)  Bone  scan  showing  non-specific 
focal  uptake  within  the  right  femur.  (c)  Computed 
tomography (CT) right femur showing a multiloculated lytic 
lesion within the medulla. (d) CT chest showing right upper 
lobe  fibrosis.  (e)  CT  abdomen  showing  multiple  splenic 
hypodensities  suggestive  of  pyogenic  abscesses.  (f) 
Magnetic  resonance  imaging  (MRI)  right  femur  showing 
extensive  necrotic  areas  secondary  to  osteomyelitis 
involving the femoral shaft. 
Despite  broad  spectrum  antibiotic  treatment  the  patient 
continued  to  be  febrile  with  increasing  right  thigh  pain. 
Magnetic resonance imaging (MRI) of the right femur was 
performed  showing  extensive  necrotic  areas  in  the  distal 
shaft of the femur, with images diagnostic of osteomyelitis 
of the right femoral shaft (Figure 1f). 
 
An  orthopaedic  referral  was  made  and  the  patient 
proceeded to osteotomy with reaming and washout. Intra-
operatively an extensive amount of purulent and necrotic 
tissue  was  removed  from  the  intramedullary  canal. 
Microscopy  showed  a  Gram-negative  bacillus  and 
Burkholderia  pseudomallei  was  isolated  from  intra-
operative tissue and bone cultures.  
 
The  patient  was  commenced  on  a  10-week  course  of 
intravenous meropenem with concurrent high-dose oral co-
trimoxazole  and  folate  supplementation.  Thereafter,  he 
made a rapid recovery with pain and fevers subsiding as the 
C-reactive protein level normalised. Given the severity of his 
disease he was discharged on a prolonged 12-month course 
of  oral  co-trimoxazole  with  monthly  follow-up  to  track 
clinical progress, bone recovery and the splenic abscesses. 
 
Discussion 
Melioidosis is a tropical disease, with the highest incidence 
occurring  in  Thailand  and  northern  Australia.
4  It  is  also 
endemic  in  Vietnam,  Laos,  Malaysia,  Indonesia  and 
Singapore. 
 
As  melioidosis  can  affect  virtually  any  organ,  clinical 
manifestations are protean and may mimic other infectious 
diseases.  Osteomyelitis  is  a  relatively  uncommon 
presentation  of  melioidosis,  occurring  in  about  4%  of 
cases.
3,5  Melioidosis  most  commonly  presents  with 
pneumonia, but in this case the patient had no respiratory 
symptoms  and  bronchoalveolar  lavage  was  negative  for 
Burkholderia.  Melioidosis  is  also  known  to  cause  internal 
organ abscesses, including splenic abscesses as seen here. 
 
The mainstay of diagnosis remains Gram stain and culture.
6 
The  indirect  haemagglutination  assay  (IHA)  is  also  widely 
used however it may be of limited clinical utility in areas of 
high background seropositivity. Sensitive nucleic acid tests 
are in development. 
 
Initial treatment of melioidosis is with intensive intravenous 
antibiotics, either ceftazidime, imipenem or, as used in this 
case, meropenem.
7 Eradication therapy requires prolonged 
oral antibiotics to prevent disease recurrence. Current trials 
are  evaluating  the  use  of  co-trimoxazole  alone  or  its  Australasian Medical Journal [AMJ 2012, 5, 2, 141-143] 
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combination  with  other  oral  agents.
6  Surgical  drainage  of 
large abscesses is also an important part of management.
2 
 
We have described a rare case of melioidotic osteomyelitis 
of  the  femur  presenting  as  fever  in  a  returned  traveller. 
Clinicians  should  maintain  a  high  index  of  suspicion  in 
patients who have lived in, or are travelling from, endemic 
regions.  The  prognosis  for  localised  disease  is  favourable 
but  mortality  is  high  if  septicaemia  develops,  thus  early 
identification  and  institution  of  appropriate  antibiotic 
treatment is essential.
2,3,7 Adult patients require long-term 
follow-up due to the risk of relapse. 
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